Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

NCT02716714 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: ingenol mebutate gel 0.015%
DRUG: ingenol mebutate gel 0.05%

Sponsor

Korea University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]